Imperial College, London, United Kingdom. RATIONALE: No previous studies were done to check the prevalence of asthma, allergic rhinitis and sensitization among the Inuit children living in Nunavut. METHODS: A cross-sectional study among grade one students attending schools in Iqaluit, the capital city of Nunavut, was conducted during the 2015/2016 school year. We used the International Study of Allergy and Asthma in Children (ISAAC) questionnaire with added questions relevant to the population and performed skin prick test to common environmental allergens. RESULTS: The prevalence of current asthma was 15.9% (>2:1 males) with the highest prevalence among those with mixed ethnicity (Inuit and non-Inuit parents) at 38.5% while lowest among the Inuit at 4.2%, this difference among ethnicities was statistically significant (Fisher's exact test 6.798 and p5 0.016). The prevalence of past asthma was 25%, also highest among the mixed ethnicity at 46.2% but lowest among the nonInuit at 14.3%. The prevalence of current and past allergic rhinitis was 6.8%, the lowest prevalence among the mixed ethnicity. High sensitization rate to cat (26.7%) while no one case to house dust mite and dog. CONCLUSIONS: Variations in the prevalence of asthma and allergic rhinitis among different ethnicities living at the same subarctic environment may be related to genetic, gene-environment interaction and/or lifestyle factors that require further investigation. Kaiser Permanente Medical Center, San Diego, CA. RATIONALE: The ACT is a widely-used, validated questionnaire for assessment of asthma control. The relationship between ACT and HRQoL requires additional assessment. METHODS: Data from the 2015-2016 U.S. National Health and Wellness Survey, a self-administered, internet-based questionnaire, were used to identify respondents aged > _18 years with a self-reported physician diagnosis of asthma. Patients were grouped by ACT score (< _15: poorlycontrolled; 16-19: partly-controlled; 20-25: well-controlled asthma). HRQoL was assessed using standard validated questionnaires: SF-36v2 metrics (SF-6D health utilities, mental component summary [MCS] , physical component summary [PCS] , and sub-domain scores) and EQ-5D-5L index score. Generalized linear models examined the association between HRQoL and ACT score, adjusting for patient characteristics. RESULTS: Overall, 1,360, 1,572, and 4,888 patients had ACT< _15, 16-19 and 20-25, respectively. ACT520-25 patients had higher adjusted mean EQ-5D-5L index scores (0.81) versus ACT516-19/< _15 (0.76/0.71). Adjusted SF-36 scores (MCS; PCS; SF-6D health utilities) were higher for 49.41; 45.91; 0.65) and ACT< _15 (39.99; 43.30; 0.61) . A similar pattern was found for the SF-36 mental and physical sub-domain scores. Adjusted HRQoL differences for ACT520-25 versus ACT516-19/< _15 exceeded the Minimal Important Difference (MID) for SF-36 MCS and PCS (MID53 each) and SF-6D health utilities index (MID50.041). Mean differences in scores for ACT520-25 versus ACT< _15 exceeded the MID for EQ-5D-5L index (MID50.07). All results were significant at p<0.001. CONCLUSIONS: In this study, higher ACT scores correlated with higher HRQoL. Incremental improvements in ACT scores could confer HRQoL benefits for asthma patients.
